Document Detail


Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells.
MedLine Citation:
PMID:  10228559     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
ERCC-1 is an essential gene in the nucleotide excision repair pathway, and may be essential for life. However, the mechanism of transcriptional activation and regulation of ERCC-1 gene expression is unclear. We therefore investigated the effect of the phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) on the expression of the ERCC-1 gene in A2780/CP70 human ovarian carcinoma cells. TPA induced a four- to sixfold increase in steady-state ERCC-1 messenger RNA (mRNA) levels that was time- and concentration-dependent. Nuclear run-on experiments demonstrated that the rate of transcription of ERCC-1 was approximately 2.8-fold higher in TPA-treated cells than in the controls. TPA stimulation of A2780/CP70 cells also resulted in a rapid but transient induction of c-jun and c-fos as determined by Northern and Western blot analyses, which peaked about 2 h before the peak in ERCC-1 expression. Electrophoretic mobility shift assays of nuclear extracts from TPA-treated cells revealed an increase in DNA-binding activity specific for the AP-1-like binding site in the 5'-flanking region of ERCC-1. c-Jun and c-Fos proteins were confirmed to be the components of the activated AP-1 complex by supershift analysis. The increase in AP-1 activity occurs immediately before the increase in ERCC-1 transcription. The increase in AP-1 DNA-binding activity and the increase in ERCC-1 mRNA expression were prevented by pretreatment with cycloheximide. These data suggest that AP-1 may contribute to the upregulation of ERCC-1 in response to TPA in human ovarian cancer cells.
Authors:
Q Li; L Zhang; B Tsang; K Gardner; F Bostick-Bruton; E Reed
Related Documents :
7850019 - Dynamic changes in the composition of the ap-1 transcription factor dna-binding activit...
8799209 - Overexpression of basal c-fos and c-jun but not of ras oncogenes after theiler's murine...
10763499 - Expression of the immediate early genes c-fos and c-jun after head injury in man.
10509709 - Expression of fos and jun proteins following passive avoidance training in the day-old ...
10449779 - Transgenic mice demonstrate ap-1 (activator protein-1) transactivation is required for ...
7970709 - Transformation by raf and other oncogenes renders cells differentially sensitive to gro...
24938929 - β-catenin regulates nf-κb activity and inflammatory cytokine expression in bronchial ep...
20374039 - Ambient tonicity and intestinal cytochrome cyp3a.
24960059 - The changes of mirna expression in rat hippocampus following chronic lead exposure.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cellular and molecular life sciences : CMLS     Volume:  55     ISSN:  1420-682X     ISO Abbreviation:  Cell. Mol. Life Sci.     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-05-19     Completed Date:  1999-05-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9705402     Medline TA:  Cell Mol Life Sci     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  456-66     Citation Subset:  IM    
Affiliation:
Developmental Therapeutics Department, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amanitins / pharmacology
Binding Sites
Carcinogens / pharmacology*
Cycloheximide / pharmacology
DNA Repair / drug effects*
DNA-Binding Proteins*
Endonucleases*
Female
Gene Expression Regulation, Neoplastic / drug effects*
Humans
Neoplasm Proteins / genetics*
Nucleic Acid Synthesis Inhibitors / pharmacology
Ovarian Neoplasms / metabolism,  pathology*
Protein Synthesis Inhibitors / pharmacology
Proteins / genetics*
RNA, Messenger / biosynthesis*,  genetics
RNA, Neoplasm / biosynthesis*,  genetics
Tetradecanoylphorbol Acetate / pharmacology*
Transcription Factor AP-1 / physiology*
Transcription, Genetic / drug effects*
Tumor Cells, Cultured
Chemical
Reg. No./Substance:
0/Amanitins; 0/Carcinogens; 0/DNA-Binding Proteins; 0/Neoplasm Proteins; 0/Nucleic Acid Synthesis Inhibitors; 0/Protein Synthesis Inhibitors; 0/Proteins; 0/RNA, Messenger; 0/RNA, Neoplasm; 0/Transcription Factor AP-1; 16561-29-8/Tetradecanoylphorbol Acetate; 66-81-9/Cycloheximide; EC 3.1.-/ERCC1 protein, human; EC 3.1.-/Endonucleases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A common ancestor for a subunit in the mitochondrial proton-translocating NADH:ubiquinone oxidoreduc...
Next Document:  Protein kinase-dependent overexpression of the nuclear protein pirin in c-JUN and RAS transformed fi...